142 related articles for article (PubMed ID: 20075119)
1. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.
Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M
Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119
[TBL] [Abstract][Full Text] [Related]
2. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
[TBL] [Abstract][Full Text] [Related]
3. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
4. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
5. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
[TBL] [Abstract][Full Text] [Related]
6. A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction.
González P; Díez-Juan A; Coto E; Alvarez V; Reguero JR; Batalla A; Andrés V
BMC Biol; 2004 Apr; 2():5. PubMed ID: 15061869
[TBL] [Abstract][Full Text] [Related]
7. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk.
Silva SN; Gil OM; Oliveira VC; Cabral MN; Azevedo AP; Faber A; Manita I; Ferreira TC; Limbert E; Pina JE; Rueff J; Gaspar J
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2407-12. PubMed ID: 16214924
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphisms.
Baida A; Farrington SM; Galofré P; Marcos R; Velázquez A
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):638-42. PubMed ID: 15767343
[TBL] [Abstract][Full Text] [Related]
10. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
11. The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer.
Morari EC; Leite JL; Granja F; da Assumpção LV; Ward LS
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1485-8. PubMed ID: 12433731
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
13. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
Pasquali D; Circelli L; Faggiano A; Pancione M; Renzullo A; Elisei R; Romei C; Accardo G; Coppola VR; De Palma M; Ferolla P; Grimaldi F; Colao A; Colantuoni V
Eur J Endocrinol; 2011 Mar; 164(3):397-404. PubMed ID: 21177330
[TBL] [Abstract][Full Text] [Related]
14. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
15. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
16. The V109G polymorphism in the p27 gene is associated with endometriosis.
Camargo-Kosugi CM; da Silva ID; Sato H; D'Amora P; Carvalho CV; Nogueira-de-Souza NC; Girão MJ; Schor E
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):180-3. PubMed ID: 19493606
[TBL] [Abstract][Full Text] [Related]
17. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
18. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
19. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.
Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS
Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in GTF2H1 and risk of lung cancer: a case-control analysis in a Chinese population.
Wu W; Liu H; Lei R; Chen D; Zhang S; Lv J; Wang Y; Fan W; Qian J; Jin G; Ma H; Miao R; Hu Z; Wang H; Jin L; Wei Q; Shen H; Huang W; Lu D
Lung Cancer; 2009 Feb; 63(2):180-6. PubMed ID: 18692935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
